４−（４−（３−（４−クロロ−３−（トリフルオロメチル）フェニル）ウレイド）−フェノキシ）−Ｎ−（１’，１’，１’−トリデューテロメチル）ピコリンアミドのｐ−トルエンスルホン酸塩（ＣＭ４３０７・ＴｓＯＨ）、ＣＭ４３０７・ＴｓＯＨの製造方法、及びＣＭ４３０７・ＴｓＯＨを含有する医薬組成物

摘要

Methods and processes for preparation and production of deuterated É-diphenylurea are disclosed. Especially, a kind of deuterated É-diphenylurea compounds which can inhibit phosphokinase and the preparation method of N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N- d3 -methylcarbamoyl)-4-pridinylox y)phenyl)urea are disclosed. The said deuterated diphenylurea compounds can be used for treating or preventing tumors and relative diseases.